No profile data available.
Par Drugs and Chemicals Limited (PAR.NS) is a healthcare company in the drug manufacturing contractors industry, based in Vadodara, India, with about 118 full-time employees.
It reported revenue of 1.01 billion INR for fiscal year 2025, up 5.7% from fiscal year 2024, and net income of 133.58 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 293.40 million INR, up 37.2% from a year before. India was its largest region in fiscal year 2025, with 75% of revenue. Its market capitalization was 1.44 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
Par Drugs and Chemicals reported 1.01 billion INR in revenue for fiscal year 2025, up 5.7% from 951.07 million INR in fiscal year 2024. In Q3 2026 revenue was 293.40 million INR.
India: 75% of revenue by region in fiscal year 2025, followed by Export (25%).
1.44 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Kimia Biosciences Limited (KIMIABL.BO), Godavari Drugs Limited (GODAVARI.BO), Bal Pharma Limited (BALPHARMA.NS), Krebs Biochemicals & Industries Limited (KREBSBIO.NS).